Норвегія -
норвезька -
Statens legemiddelverk
azyter 15 mg/ g
laboratoires théa s.a.s - azitromycindihydrat - Øyedråper, oppløsning - 15 mg/ g
Європейський Союз -
норвезька -
EMA (European Medicines Agency)
adempas
bayer ag - riociguat - hypertensjon, pulmonal - antihypertensive midler for pulmonal arteriell hypertensjon - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. effekten har vært vist i en pah befolkningen, herunder aetiologies av idiopatisk eller heritable pah eller pah assosiert med bindevev sykdom. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.
Європейський Союз -
норвезька -
EMA (European Medicines Agency)
pedea
recordati rare diseases - ibuprofen - ductus arteriosus, patent - hjertetapi - behandling av en hemodynamisk signifikant patentsduktus arteriosus hos premature nyfødte spedbarn mindre enn 34 uker med graviditetsalder.
Норвегія -
норвезька -
Statens legemiddelverk
combigan 2 mg/ ml / 5 mg/ ml
abbvie as - brimonidintartrat / timololmaleat - Øyedråper, oppløsning - 2 mg/ ml / 5 mg/ ml
Норвегія -
норвезька -
Statens legemiddelverk
cetraxal comp 3 mg/ ml / 0.25 mg/ ml
poa pharma scandinavia ab - ciprofloksacinhydroklorid / fluocinolonacetonid - Øredråper, oppløsning i endosebeholder - 3 mg/ ml / 0.25 mg/ ml
Норвегія -
норвезька -
myHealthbox
hussar plus od
bayer ag - jodsulfuron 50 g/l; mesosulfuron 7,5 g/l